Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04439929 |
|
Recruitment Status :
Completed
First Posted : June 19, 2020
Last Update Posted : June 19, 2020
|
Sponsor:
Turgut İlaçları A.Ş.
Information provided by (Responsible Party):
Turgut İlaçları A.Ş.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | January 16, 2020 |
| Actual Study Completion Date : | January 16, 2020 |